Shares of medical technology company Teleflex (NYSE:TFX) fell 5.4% in the afternoon session after the U.S. government launched a probe into the medical device industry. The investigation appeared to ...
The latest price target for Teleflex (NYSE:TFX) was reported by Truist Securities on May 5, 2025. The analyst firm set a price target for $137.00 expecting TFX to rise to within 12 months (a possible ...
Teleflex is launching new products, acquiring Biotronik’s vascular unit, and splitting into two companies to reignite growth and unlock value. Margins are strong, the balance sheet is solid, and cash ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback